Exiqon AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
23
About the Report
About the Report
Summary
Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products, among others. It offers microRNA research products such as RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits and functional analysis, among others. Exiqon provides services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service, among others. The company's products find applications in isolation, microarray analysis, northern blotting, real-time PCR, in situ hybridization, functional analysis and SNP detection, among others. It operates in Denmark and the US. Exiqon is headquartered in Copenhagen, Denmark.
Exiqon AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Exiqon AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exiqon AS, Medical Devices Deals, 2012 to YTD 2018 9
Exiqon AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Exiqon AS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Takara Bio Enters Into Co-Marketing Agreement With Exiqon For miRCURY LNA Products 11
Licensing Agreements 12
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 12
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 13
Transgenomic Expands Licensing Agreement with Exiqon 14
Equity Offering 15
Exiqon Completes Private Placement Of Shares For USD 2.6 Million 15
Debt Offering 16
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 16
Exiqon Completes Private Placement Of Bonds For USD 3 Million 17
Acquisition 18
Qiagen Acquires Exiqon for up to USD102.4 Million 18
Exiqon AS-Key Competitors 20
Exiqon AS-Key Employees 21
Exiqon AS-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Figure
List of Figures
Exiqon AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exiqon AS, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Exiqon AS, Pharmaceuticals & Healthcare, Key Facts 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Deals By Therapy Area, 2012 to YTD 2018 8
Exiqon AS, Medical Devices Deals, 2012 to YTD 2018 9
Exiqon AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Takara Bio Enters Into Co-Marketing Agreement With Exiqon For miRCURY LNA Products 11
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 12
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 13
Transgenomic Expands Licensing Agreement with Exiqon 14
Exiqon Completes Private Placement Of Shares For USD 2.6 Million 15
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 16
Exiqon Completes Private Placement Of Bonds For USD 3 Million 17
Qiagen Acquires Exiqon for up to USD102.4 Million 18
Exiqon AS, Key Competitors 20
Exiqon AS, Key Employees 21
Exiqon AS, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.